Laura Foley , Marina Steiner-Browne , Emmet O'Reilly
{"title":"Stabilising large biologics through complimentary buffer component protection and rapid drying times","authors":"Laura Foley , Marina Steiner-Browne , Emmet O'Reilly","doi":"10.1016/j.ijpx.2025.100374","DOIUrl":null,"url":null,"abstract":"<div><div>High processing temperatures restrict spray drying applications for heat sensitive biologics. This work highlights the potential of Phosphate Buffer Saline (PBS) as the sole stabilising excipient when spray drying large biologics via a complimentary buffer component effect. Fibrinogen (∼340 kDa) was spray dried in PBS at various temperatures and concentrations, followed by assessment of the protein's structural integrity by UV–Vis, ATR-FTIR, SEM, and PXRD analyses. Experimental findings demonstrate that fibrinogen can maintain structural integrity when spray dried at temperatures up to 60 °C (T<sub>out</sub>), when PBS is used as the sole stabilising excipient in combination with rapid drying rates. Results show a synergistic effect between the phosphate and salt components of the buffer when subjected to rapid drying rates mitigating protein aggregation and preserving protein secondary and tertiary structures. Stability studies conducted over 90 days indicated that powders stored under low humidity retained structural integrity. Findings provide valuable insights into the feasibility of spray drying large biologics through understanding the individual stabilising effects of PBS buffer components coupled with the rapid drying times. This approach offers a promising and scalable formulation strategy for the pharmaceutical industry in developing an alternative to freeze drying methods, offering advantages in cost, processing time, and product stability.</div></div>","PeriodicalId":14280,"journal":{"name":"International Journal of Pharmaceutics: X","volume":"10 ","pages":"Article 100374"},"PeriodicalIF":6.4000,"publicationDate":"2025-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Pharmaceutics: X","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590156725000593","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
High processing temperatures restrict spray drying applications for heat sensitive biologics. This work highlights the potential of Phosphate Buffer Saline (PBS) as the sole stabilising excipient when spray drying large biologics via a complimentary buffer component effect. Fibrinogen (∼340 kDa) was spray dried in PBS at various temperatures and concentrations, followed by assessment of the protein's structural integrity by UV–Vis, ATR-FTIR, SEM, and PXRD analyses. Experimental findings demonstrate that fibrinogen can maintain structural integrity when spray dried at temperatures up to 60 °C (Tout), when PBS is used as the sole stabilising excipient in combination with rapid drying rates. Results show a synergistic effect between the phosphate and salt components of the buffer when subjected to rapid drying rates mitigating protein aggregation and preserving protein secondary and tertiary structures. Stability studies conducted over 90 days indicated that powders stored under low humidity retained structural integrity. Findings provide valuable insights into the feasibility of spray drying large biologics through understanding the individual stabilising effects of PBS buffer components coupled with the rapid drying times. This approach offers a promising and scalable formulation strategy for the pharmaceutical industry in developing an alternative to freeze drying methods, offering advantages in cost, processing time, and product stability.
期刊介绍:
International Journal of Pharmaceutics: X offers authors with high-quality research who want to publish in a gold open access journal the opportunity to make their work immediately, permanently, and freely accessible.
International Journal of Pharmaceutics: X authors will pay an article publishing charge (APC), have a choice of license options, and retain copyright. Please check the APC here. The journal is indexed in SCOPUS, PUBMED, PMC and DOAJ.
The International Journal of Pharmaceutics is the second most cited journal in the "Pharmacy & Pharmacology" category out of 358 journals, being the true home for pharmaceutical scientists concerned with the physical, chemical and biological properties of devices and delivery systems for drugs, vaccines and biologicals, including their design, manufacture and evaluation. This includes evaluation of the properties of drugs, excipients such as surfactants and polymers and novel materials. The journal has special sections on pharmaceutical nanotechnology and personalized medicines, and publishes research papers, reviews, commentaries and letters to the editor as well as special issues.